Arsenic promotes ROS-mediated malignant transformation of bronchial epithelial cells by specifically downregulating

Lingling Zhao1, Xueli Jiao2,3, Hongyan Li2

  • 1Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China. zhaolingling@wmu.edu.cn.

Communications Biology
|November 22, 2025
PubMed

Insights

Arsenic exposure downregulates thioredoxin-like 1 (TXNL1) by affecting USP10 and DNMT1, increasing lung cancer risk. Restoring TXNL1 may prevent arsenic-induced cancer.

Area of Science:

  • Environmental Health
  • Molecular Biology
  • Cancer Research

Background:

  • Arsenic exposure is a known lung carcinogen, linked to reactive oxygen species (ROS) and DNA damage.
  • The exact mechanisms by which arsenic influences ROS levels are not fully understood.

Purpose of the Study:

  • To elucidate the role of thioredoxin-like 1 (TXNL1) in arsenic-induced lung carcinogenesis.
  • To investigate the molecular pathways through which arsenic affects TXNL1 expression and redox homeostasis.

Main Methods:

  • In vitro and in vivo studies to assess TXNL1 expression.
  • Investigating the impact of TXNL1 enhancement on arsenic-induced cellular changes.
  • Analyzing the roles of USP10 and DNMT1 in arsenic's effect on TXNL1.

Main Results:

  • Arsenic downregulates TXNL1 expression, contrary to other ROS scavenging genes.
  • Increased TXNL1 suppresses arsenic-induced ROS, DNA damage, and malignant transformation.
  • Arsenic downregulates USP10, leading to TXNL1 degradation, and upregulates DNMT1, causing USP10 promoter hypermethylation.

Conclusions:

  • Arsenic disrupts redox homeostasis through the DNMT1-USP10-TXNL1 pathway.
  • This pathway represents a potential therapeutic target for preventing arsenic-induced lung cancer.